Safety, Tolerability and Pharmacokinetic Studies of HRS-2183 for Injection in Healthy Chinese Subjects After Single and Multiple Administration

NCT07232758 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Chinese Healthy Adult Subjects

Interventions

DRUG: HRS-2183
DRUG: Placebo

Sponsor

Jiangsu HengRui Medicine Co., Ltd.